Stock Researching

Can Argos Succeed Where Dendron Failed

Stock Researching
Publish date: Wed, 01 Jan 2014, 10:18 AM
Stock Researching
0 251,608
Stockresearching is a blog designed to help the independent investor create new ideas and receive valuable informed information.
Following Message

From Liston Street Pulse:

Argos Therapeutics, a North Carolina based biotech company, plans to raise $60 million through its initial public offering filed with the SEC on December 30, 2013. Money raised through the IPO is to be used for the late stage study of the company's lead candidate, AGS-003, for personalized cancer treatment. […]

The post Can Argos Succeed Where Dendron Failed appeared first on Liston Street Pulse.

More articles on Stock Researching
Visa Inc: Inside the Numbers 2016 $V

Created by Stock Researching | Dec 17, 2016

Enbridge Inc: 2016 Fundamental Analysis WACC, Cost of Debt and Cost of Equity $ENB

Created by Stock Researching | Dec 13, 2016

Apple Inc: DCF Calculation Apple Inc. $AAPL

Created by Stock Researching | Dec 10, 2016

Apple Inc: Fundamental Analysis WACC, Cost of Debt and Cost of Equity $AAPL

Created by Stock Researching | Dec 04, 2016

Visa Inc: DCF Calculation Visa Inc. $V

Created by Stock Researching | Dec 03, 2016

Visa Inc: Fundamental Analysis WACC, Cost of Debt and Cost of Equity $V

Created by Stock Researching | Dec 02, 2016

Telus Corp. Cost of Debt, CAPM, WACC and Valuation $TU, $T.TO

Created by Stock Researching | Nov 19, 2016

Assessing Canadian Telecom Exposure, $BCE is worth a look

Created by Stock Researching | Nov 10, 2016

J&J Current Valuation. Is This The Time To Buy? $JNJ

Created by Stock Researching | Sep 17, 2016

$UPS Deriving Value From E-Commerce Growth And Lower Energy Prices

Created by Stock Researching | Oct 05, 2015

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment